Integral Diagnostics Limited

IDX

AU000000IDX2

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 02:10:14 2024-05-09 am EDT			5-day change	1st Jan Change
2.44 ^AUD	-2.40%		-0.81%	+28.08%

Mar. 06	Morgan Stanley Adjusts Integral Diagnostics’ Price Target to AU$1.85 From AU$1.70, Keeps at Underweight	MT
Feb. 21	Jarden Research Adjusts Integral Diagnostics’ Price Target to AU$2.59 From AU$2.54, Keeps at Neutral	MT

Integral Diagnostics Limited(ASX:IDX) added to S&P/ASX 300 Index

June 22, 2020 at 12:00 am EDT

Latest news about Integral Diagnostics Limited

Morgan Stanley Adjusts Integral Diagnostics’ Price Target to AU$1.85 From AU$1.70, Keeps at Underweight	Mar. 05	MT
Jarden Research Adjusts Integral Diagnostics’ Price Target to AU$2.59 From AU$2.54, Keeps at Neutral	Feb. 20	MT
Integral Diagnostics Shares Gain 2%; Posts 7% Rise in H1 FY24 Revenue, Profit Slips	Feb. 19	MT
Transcript : Integral Diagnostics Limited, H1 2024 Earnings Call, Feb 20, 2024	Feb. 19
Integral Diagnostics Reports H1 FY24 Revenue Up 7% to AU$231.3 Million; EPS of AU$0.031	Feb. 19	MT
Integral Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 19	CI
IDX? Announces Appointment of Scott Paterson as Worldwide CFO	Feb. 07	CI
Integral Diagnostics Limited Announces Change of Company Secretary	Dec. 11	CI
Integral Diagnostics Limited Announces Resignation of Helen Kurincic as Director Effective 29 November 2023	Nov. 29	CI
Transcript : Integral Diagnostics Limited - Shareholder/Analyst Call	Nov. 28
4DMedical Enters Agreement with Integral Diagnostics for XV Technology Distribution; Shares Jump 9%	23-10-29	MT
Integral Diagnostics Announces Release of Certain Shares from Voluntary Escrow	23-10-10	MT
Integral Diagnostics Appoints Chair Elect	23-09-28	MT
Integral Diagnostics Limited Appoints Toby Hall as Director	23-09-27	CI
Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Six Months Ended June 30, 2023, Payable on October 04, 2023	23-09-25	CI
Integral Diagnostics Raises Final Dividend as Fiscal 2023 Profit Rises	23-08-27	MT
Transcript : Integral Diagnostics Limited, 2023 Earnings Call, Aug 28, 2023	23-08-27
Integral Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27	CI
Integral Diagnostics Limited Declares Fully Franked Final Dividend, Payable on October 04, 2023	23-08-27	CI
Integral Diagnostics Limited Announces Board Changes	23-08-09	CI
Integral Diagnostics Discloses Release of Shares from Voluntary Escrow	23-08-07	MT
Integral Diagnostics Discloses Release of Shares from Voluntary Escrow in July	23-06-20	MT
Integral Diagnostics Grows Fiscal H1 Profit, Lowers Interim Dividend; Shares Down 16%	23-02-16	MT
Transcript : Integral Diagnostics Limited, H1 2023 Earnings Call, Feb 17, 2023	23-02-16
Integral Diagnostics Limited Announces Ordinary Dividend for the Six Months Ended December 31, 2022, Payable on April 4, 2023	23-02-16	CI

Chart Integral Diagnostics Limited

Duration

Period

More charts

Integral Diagnostics Limited is an Australia-based provider of medical imaging services across Australia and New Zealand. It provides diagnostic services to patients and their referrers across Australia and New Zealand. It operates brands in four Australian States: Lake Imaging in Victoria, the X-Ray Group in VIC/NSW, South Coast Radiology, Peloton Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. It also operates in New Zealand through the Astra Radiology, SRG Radiology, Horizon Radiology and Trinity MRI brands. Lake Imaging offers a private radiology service to patients throughout Central and Western Victoria. South Coast Radiology provides medical imaging services and patient care to the Gold Coast and Tweed Heads communities. Imaging Queensland is a provider of advanced diagnostic imaging services and radiology education across Queensland. Apex Radiology provides diagnostic imaging services for patients in rural and regional communities.

Sector

Healthcare Facilities & Services

Calendar

2024-08-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Integral Diagnostics Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.44 AUD

Average target price

2.523 AUD

Spread / Average Target

+3.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
INTEGRAL DIAGNOSTICS LIMITED	+28.08%	384M
SONIC HEALTHCARE LIMITED	-17.08%	8.39B
RADNET, INC.	+53.87%	3.74B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-37.54%	2.55B
SYNLAB AG	-9.63%	2.48B
DR. LAL PATHLABS LIMITED	-13.43%	2.32B
NEOGENOMICS, INC.	-5.28%	1.93B
FLEURY S.A.	-17.79%	1.6B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-36.41%	1.28B
METROPOLIS HEALTHCARE LIMITED	+2.19%	1.08B

Medical & Diagnostic Laboratories